Day: September 19, 2022

Miovision launches Scout Explore

The first portable video-based traffic data collection solution to offer on-device processing capabilities LOS ANGELES, Sept. 19, 2022 (GLOBE NEWSWIRE) — ITS World Congress – Today, Miovision announced its next-generation portable video-based traffic data collection solution – Miovision Scout® Explore. Thanks to advanced AI, Scout Explore is the first portable

GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)

Promising efficacy and safety profiles were observed in prior Phase II studies in acute ischemic stroke patients treated with recanalization therapies. The ENIS-3 trial has achieved >33% of target enrollment (948 patients). The independent data monitoring committee (IDMC) has completed interim analysis and indicated that the trial should continue. The

DollarBack Comes to the Rescue of Crypto Scam Victims

Featured Image for Dollarback ZURICH, Sept. 19, 2022 (GLOBE NEWSWIRE) — For any crypto investor, it’s nothing unusual to come across scammers. While it’s undeniable that the number of these fraudsters is increasing alarmingly across the cryptospace, it’s shockingly true that more and more people continue to get hoodwinked through

Codex DNA Debuts Next-Generation Automated Synthetic Biology Workstation

BioXp™ 9600 system – a fully automated, high-throughput benchtop instrument for synthetic biology workflows – empowers scientists to accelerate discovery of new vaccines and biologics SAN DIEGO, Sept. 19, 2022 (GLOBE NEWSWIRE) — Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced commercial release